$0.9343
0.004300.46%
At close: -
$0.8300
-0.10-11.16%
After Hours: Apr 25, 7:59 PM EDT
Comments
Loading...
Silexion Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SLXN | Benzinga
Silexion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 18
EPS
$14.240
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Silexion Therapeutics using advanced sorting and filters.
Silexion Therapeutics (SLXN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Silexion Therapeutics (SLXN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Silexion Therapeutics (NASDAQ:SLXN) reporting earnings?
Silexion Therapeutics (SLXN) is scheduled to report earnings on May 21, 2025. The last reported earnings were for reported on March 18, 2025 for Q4.
What were the latest earnings per share (EPS) for Silexion Therapeutics (NASDAQ:SLXN)?
The Actual EPS was $14.24, which beat the estimate of $0.00.
What were Silexion Therapeutics’s (NASDAQ:SLXN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
